Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer’s Disease Patients by Integrated Bioinformatics
Fang Wang, Jia Xu, Shujun Xu, et al.
Journal of Alzheimer s Disease (2021) Vol. 85, Iss. 2, pp. 729-744
Open Access | Times Cited: 11

Showing 11 citing articles:

Alzheimer’s disease and COVID-19: Interactions, intrinsic linkages, and the role of immunoinflammatory responses in this process
Wei Li, Lin Sun, Ling Yue, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
The viral hypothesis in Alzheimer’s disease: SARS-CoV-2 on the cusp
Nanyang Liu, Xuefan Jiang, Hao Li
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 14
A review and analysis of key biomarkers in Alzheimer’s disease
Zhihao Zhang, Xiangtao Liu, Suixia Zhang, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5
SARS-CoV-2 infection increases the gene expression profile for Alzheimer’s disease risk
Ryan Green, Karthick Mayilsamy, Andrew R. McGill, et al.
Molecular Therapy — Methods & Clinical Development (2022) Vol. 27, pp. 217-229
Open Access | Times Cited: 22
COVID‐19 and neurodegeneration: The mitochondrial connection
Christopher Anthony Denaro, Yara I. Haloush, Samuel Yien Hsiao, et al.
Aging Cell (2022) Vol. 21, Iss. 11
Open Access | Times Cited: 17
Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer’s Disease
Nikita Navolokin, Viktoria Adushkina, Daria Zlatogorskaya, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 788-788
Open Access | Times Cited: 3
Immune landscape and redox imbalance during neurological disorders in COVID-19
Abhimanyu Thakur, Vartika Sharma, Sera Averbek, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 7
Unlocking the Protective Potential of Upper Respiratory Infection Treatment Histories against Alzheimer’s Disease: A Korean Adult Population Study
Ho Suk Kang, Ji Hee Kim, Joo‐Hee Kim, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 1, pp. 260-260
Open Access | Times Cited: 2
Adaptive best subset selection algorithm and genetic algorithm aided ensemble learning method identified a robust severity score of COVID‐19 patients
Weikaixin Kong, Jie Zhu, Suzhen Bi, et al.
iMeta (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 5
Blood transcriptome and machine learning identified the crosstalk between COVID-19 and fibromyalgia: a preliminary study
Zhao Zhang, Zhijie Zhu, Dong Liu, et al.
Clinical and Experimental Rheumatology (2022)
Open Access | Times Cited: 7
Global trends in COVID-19 Alzheimer's related research: a bibliometric analysis
Chenjun Cao, Sixin Li, Gaoya Zhou, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access
Page 1

Scroll to top